Klaviyo Inc. Series A stocks have been trading up by 10.16 percent amid bullish sentiment on its marketing automation growth.
Click Here for a Millionaire's POV on Trading KVYO
SUBSCRIBE FOR ALERTSJOIN 50,000+ ACTIVE TRADERS
Key Takeaways
- Goldman Sachs cut Klaviyo’s rating from Buy to Neutral with a $20 target, while the broader Street still leans Buy with a mean target of $26.24.
- Following the downgrade, KVYO slid about 6.5% and traded near $16.91 on lighter-than-average volume, signaling pressure but not panic selling.
- Klaviyo plans to post Q3 2026 results after the close on 2026/11/04, with a webcast available through its investor relations site.
- A separate piece highlighted Tony Weisman’s board role at both Ibotta and Klaviyo but offered no fresh detail on KVYO’s fundamentals.
- Another article mentioned KVYO only in a ticker list, underscoring that current trading focus is squarely on the downgrade and the coming earnings report.
Live Update At 12:33:21 EDT: On Tuesday, October 20, 2026 Klaviyo Inc. Series A stock [NYSE: KVYO] is trending up by 10.16%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Quick Financial Overview
Klaviyo Inc. Series A has been grinding higher on the daily chart. Over the last few weeks, KVYO has climbed from the mid-$15s to around $19.30, with recent closes stepping up from $15.71 on 2026/10/02 to $19.2999 on 2026/10/20. That’s a solid near-term uptrend despite the Goldman noise.
Intraday, KVYO shows tight trading between roughly $19.00 and $19.40 for much of the latest session, with only brief dips toward $18.60 at the open. That kind of contained range tells traders there’s active two-sided action but no blowout capitulation. Buyers are still showing up around each small pullback.
More Breaking News
- QSI Stock Holds Key Level As Proteus Milestones Pile Up
- SKHY Stock Slides As CXMT DRAM Claims Rattle Memory Trade
- AIXI Stock Whipsaws As Traders Target AI Volatility
- FRGT Stock Whipsaws Higher As Volatility Attracts Day Traders
On the fundamentals, Klaviyo reported about $370.6M in quarterly revenue and a strong gross margin near 73.8%. KVYO is still running slightly in the red, with a quarterly net loss around $8.8M and an EBIT margin below zero, but it generated about $93.9M in operating cash flow and roughly $82.9M in free cash flow. Low debt, a current ratio around 3.1, and over $832.6M in cash give KVYO a sizable cushion. For traders, that mix screams “growth name with room to maneuver,” but the sky-high headline P/E simply reflects early-stage profitability noise.
Why Traders Are Watching KVYO Now
The real jolt for KVYO came when Goldman Sachs stepped back from its previous bullish stance. The bank downgraded Klaviyo from Buy to Neutral and slapped a $20 price target on the stock. That’s only a modest premium to the recent $16.91 trading level, so from Goldman’s lens, the easy upside in KVYO may already be gone for now.
Traders reacted fast. KVYO dropped roughly 6.5% on the day of the downgrade. But here’s the detail that matters for short-term trading strategy: volume was lighter than average. When a name like Klaviyo sells off on a downgrade but doesn’t light up the tape with massive volume, that often signals a reset rather than a full-on sentiment collapse. Some funds take risk down, algos react to the headline, but conviction sellers might still be on the sidelines.
At the same time, the broader analyst crowd continues to rate KVYO a Buy, with a mean target near $26.24. That’s a huge gap versus Goldman’s $20 level and versus current price. For active traders, this divergence is the whole game. KVYO now trades between a cautious big-bank cap on upside and a still-bullish Street view that implies much more room to run.
The next big catalyst is locked in. Klaviyo will report Q3 2026 earnings after the close on 2026/11/04, followed by a webcast and replay. That event will either validate Goldman’s cooler stance or give momentum traders ammo to push KVYO back toward those higher targets. Meanwhile, side notes like Tony Weisman’s dual board roles or stray ticker mentions add almost nothing to the near-term setup compared to that downgrade–earnings one-two punch.
Conclusion
Right now KVYO sits in a classic battleground zone that experienced traders recognize. On one side, you have Goldman Sachs stepping off the gas with a Neutral call and a $20 target, which already helped knock Klaviyo down about 6.5% and spooked some weaker hands. On the other side, the average Street target around $26.24 and the recent price recovery toward $19.30 say plenty of traders still see upside in Klaviyo.
Fundamentally, KVYO is not a busted story. Revenue growth remains strong, gross margins are elite for a software name, and the balance sheet is packed with cash and light on debt. The drag is near-term profitability and rich valuation metrics, which is exactly what sparks these types of rating cuts when sentiment cools off. Add the confirmed Q3 2026 report on 2026/11/04, and you have a clear line in the sand where expectations meet reality.
For active day and swing traders tracking KVYO, that means one thing: prepare, don’t predict. Study the daily and intraday levels, map the $20 and $26 zones, and be ready for volatility around the earnings print. As Tim Sykes loves to say, “Discipline is the only edge that never goes away.” As Tim Bohen, lead trainer with StocksToTrade says, “Success in trading is more about cutting losses quickly than finding winners.”. In a name like Klaviyo, that discipline—cutting losses fast, respecting key levels, and not marrying a bias—is what keeps traders in the game while everyone else argues about price targets.
This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.
Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.
Check out our quick startup guide for new traders!
- How to Read Stock Charts: A Guide for Beginners
- Trading Plan: 6 Steps to Create One
- How To Create a Stock Watchlist
Ready to build your watchlists? Check out these curated lists:
Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.